Max Delbrück Center
The
About Max Delbrück Center for Molecular Medicine in the Helmholtz Association
editThe Max Delbrück Center for Molecular Medicine (MDC) in the Helmholtz Association is a leading research institute dedicated to deciphering the molecular mechanisms of health and disease. With the aim of translating these insights into medical practice, the MDC conducts innovative research in an interdisciplinary environment. The center hosts 82 research groups and 18 technology platforms that address a variety of topics, including systems medicine and cardiovascular diseases.
Key Products and Services
editThe MDC is known for its groundbreaking research, which is published annually in around 450 scientific articles. Notable projects include the development of "organ-on-a-chip" technologies to model the human pancreas and the use of AI-based tools to personalize cancer therapies. The MDC also promotes the translation of research findings into practice by supporting spin-offs and industry partnerships.
Mission and Values
editThe mission of the MDC is to lay the foundations for the medicine of tomorrow. This is achieved through a strong emphasis on interdisciplinarity and collaboration. The values of the MDC include good scientific practice, open science, diversity, equality and inclusion, as well as ethical standards in research. The center actively engages in dialogue between science and society to foster trust in research.
Sustainability Goals and Initiatives
editSustainability is a core value of the MDC. The center is committed to sustainable development and integrates environmentally friendly practices into its research and operational processes. Furthermore, the MDC participates in the Helmholtz initiative to promote foundation models based on large datasets from medicine, climate, and materials science to discover new relationships and make predictions.
Current Developments
editUnder the leadership of Maike Sander, the scientific director, the MDC is driving a bold shift towards interdisciplinary research to address the most pressing health issues of our time. The center recently welcomed Dr. Nevine Shalaby as the new head of the Department of Innovation and Entrepreneurship to enhance the impact of research and support the 2030 strategy.
The Max Delbrück Center is a beacon of biomedical research in Germany and worldwide, distinguished by its innovative approaches and commitment to excellence and sustainability. It remains a central player in the global scientific community, continuously contributing to the improvement of human health.